Previous 10 | Next 10 |
– Data from three cohorts of phase 1b COSMIC-021 trial to be presented during the 2020 American Society of Clinical Oncology Virtual Scientific Program (ASCO20) – – 27% objective response rate seen in immune checkpoint inhibitor-pretreated non-small cell lung ca...
Exelixis (NASDAQ: EXEL) and bluebird bio (NASDAQ: BLUE) are two biotech companies that have been moving in opposite directions on the stock market this year. While Exelixis has provided healthy gains -- its stock is up by 52.1% year to date -- Bluebird's shares have slid by 35.2% since t...
Biotech Pulse Source: COVID-19 image by Getty Images; edits by PrudentBiotech.com It has taken a pandemic for biotechs to take flight towards their all-time high. One of the first industry groups to recover from the virus-related selloff and be neutral for the year, biotech indexes hav...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...
— Presentations to be webcast on www.exelixis.com — Exelixis, Inc. (Nasdaq: EXEL) today announced that members of Exelixis’ management team will participate in fireside chats at the following virtual investor conferences in May: BofA Securities 2020 Heal...
The following slide deck was published by Exelixis, Inc. in conjunction with their 2020 Q1 earnings Read more ...
Image source: The Motley Fool. Exelixis Inc (NASDAQ: EXEL) Q1 2020 Earnings Call May 5, 2020 , 5:00 p.m. ET Operator Continue reading
Exelixis, Inc. (EXEL) Q1 2020 Results Earnings Conference Call May 5, 2020, 5:00 PM ET Company Participants Susan Hubbard - Executive Vice President, Public Affairs and IR Michael Morrissey - President and CEO Patrick Haley - Executive Vice President, Commercial Christopher Sen...
The best way out is always through. " - Robert Frost The markets continued to hold up well last week even as containment of COVID-19 has yet to be achieved, and as economic damage from the lockdowns triggered by media-driven mass hysteria continues to accelerate. 26 million Americans have...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...
News, Short Squeeze, Breakout and More Instantly...
– Conference Call and Webcast to Follow at 5:00 p.m. ET / 2:00 p.m. PT – Exelixis, Inc. (Nasdaq: EXEL) announced today that its second quarter 2024 financial results will be released on Tuesday, August 6, 2024 after the markets close. At 5:00 p.m. ET / 2:00 p.m. PT, Ex...
2024-07-11 08:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...